“Due to recent clinical research and growing consumer awareness, the K2 market has experienced fantastic year-over-year growth,” Dan Murray, VP of business development at XSTO Solutions told us.
Murray pegged the vitamin K market growth at around 20% to 40% year-over-year, estimating its value in the $10 to $12 million range, based on his company’s own analysis and market observation.
He added that this growth is driven mostly by supplements in the bone and heart health segments. “Vitamin K2-MK7’s ability to properly utilize calcium makes it a great compliment to both calcium and Vitamin D,” he added. “We are just scratching the surface of demand for K2 as we move from specialty product status toward the mass market channel.”
K2Quest is a synthetic vitamin K that comes in oil form, which the company argues has the best stability. Murray added that it is best used in capsule form.
“Some K2 products are derived from fermentation and less than 98% pure, meaning there are inactive or unknown components present” he said. “K2Quest is a purified, all-active K2 MK7, which is what you want to consume.”